BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System

FRANKLIN LAKES, N.J., Nov. 3, 2025 /PRNewswire/ --Â BD (Becton, Dickinson and Company) (NYSE: BDX)Â a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européenne (CE) marking in the European Union for its Enteric Bacterial Panel* (EBP) and Enteric Bacterial Panel plus* (EBP plus) for the BD CORâ"¢ System. Continue Reading BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bac ...